Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/NANOVIRICIDES-INC-15311537/actualite/Nanoviricides-Inc-annonce-que-l-antiviral-a-large-spectre-Nv-387-Nv-Cov-2-en-essai-clinique-de-45348053/?utm_source=whatsapp&utm_medium=social&utm_campaign=share